CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.
PEIP Conference 2023
Another great PEIP conference occurred October 20-21, 2023.
We had over 600 attendees, both in-person and online, who enjoyed the mixture of concise, to-the-point presentations which blended humour with serious learning. We were thrilled to have outstanding speakers who focused on practical, applicable knowledge. From “Bodies Behaving Badly” to practical sessions on Orthopedics, the diversity and richness of content offered something valuable for all primary care professionals.
We’re excited to announce that PEIP 2024 is scheduled for October 18-19, 2024. Whether you prefer to join us in person or online, we promise another round of engaging, insightful, and fun sessions.
Most Recent Tools for Practice
Tools for Practice #361 Preventing RSV Infections in Infants
How safe and effective are monoclonal antibodies to prevent respiratory syncytial virus (RSV) infections in infants?
In high-risk infants (premature and/or congenital heart or lung conditions), palivizumab (4-5 doses monthly during RSV season) reduces RSV hospitalization (4.5% versus 10% placebo). Nirsevimab (one dose) reduces RSV hospitalizations in healthy premature infants (0.8% versus 4%) and term infants (0.3-0.4% versus 1.5-2.0%). Side effects are similar to placebo. Read More
Tools for Practice #360 Ketamine for Depression
What are the benefits and harms of ketamine/esketamine for depression?
Ketamine/esketamine appears effective for moderate-severe depression (helping 10-20% more people respond over placebo at 1-4 weeks). However, biases are very common and large effects are likely exaggerated. Adverse events are common (example: 20% more nausea/vomiting). Considerable uncertainty remains (treating mid/long-term, misuse risk, and long-term harms) and treatment is costly. Read More
Tools for Practice #359 Topical corticosteroids for atopic dermatitis – More than skin deep
What are the benefits/harms of topical corticosteroids for atopic dermatitis in adults/children?
Evidence is somewhat limited but topical corticosteroids are effective for atopic dermatitis and efficacy likely increases with potency. Once daily seems similarly effective to twice daily. If frequent flares, ‘weekend therapy’ (treatment 2-days/week to areas with recurrent flares) will help ~60% avoid a flare versus ~30% using placebo-cream over 16-weeks. Topical corticosteroids are well-tolerated for ≤6 weeks. Long-term harms are not available. Read More
Tools for Practice #358: Any berry good solutions to preventing UTIs: Cranberries?
Do cranberry products prevent recurrent urinary tract infections (UTIs)?
Potential benefits of cranberry products for UTI prevention are at high risk-of-bias from potential publication bias, small studies, and unblinding. If biases disregarded, cranberry products might reduce the proportion of women with recurrent UTIs from 24% to 18% over ≤1 year. Results are inconsistent between patient populations; example children with recurrent UTIs may benefit but not institutionalized elderly or pregnant woman. Read More
Tools for Practice #357: Overcoming Resistance: Antipsychotics for difficult to treat depression
In patients with treatment-resistant depression, is adding an atypical antipsychotic to current therapy safe and effective?
About 30% of patients using atypical antipsychotics as adjunctive therapy achieve a response in treatment-resistant depression compared to ~20% on placebo at 6-8 weeks. Somnolence, akathisia, and weight gain are most commonly reported adverse events occurring in 5-20% versus 1-5% for placebo. Read More
Congratulations to PEER's Tina Korownyk: Alberta Family Physician of the Year
PEER Director, Dr. Tina Korownyk was awarded the 2023 Alberta Family Physician of the year at the annual Family Medicine Forum gala in Montreal, Quebec on November 10. The PEER team joined Tina to celebrate her achievement as a wonderful physician and leader in primary care. Congratulations Tina!
PEER Values
When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.
Who is PEER?
Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers.